NCT00972933
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- University of Pittsburgh Medical Center/University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
Clinical trial condition
Melanoma
Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.
1,012 public trials
175 recruiting studies
Melanoma trial results
Completed
Moletest Clinical Study in Scotland
NCT02196246
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- NHS Lanarkshire R&D Airdrie, United Kingdom
NCT01711684
- Conditions
- Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
- Locations
-
- The Rockefeller University New York, United States
NCT00667082
- Conditions
- Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +40 more
- Locations
-
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- The Queen Elizabeth Hospital Woodville South, South Australia, Australia
- Sir Charles Gairdner Hospital and University of Western Australia Nedlands, Western Australia, Australia
NCT03165409
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Bristol-Myers Squibb Princeton, New Jersey, United States
NCT01153763
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Philadelphia, Pennsylvania, United States
NCT02574533
- Conditions
- Malignant Melanoma, Melanoma, Melanoma Recurrent, +11 more
- Locations
-
- Texas Oncology P.A., Texas Cancer Center Abilene, Texas, United States
- Mary Crowley Medical Research Centers Dallas, Texas, United States
- Cancer Care Northwest Spokane, Washington, United States
NCT01622933
- Conditions
- Disease Attributes, Melanoma, Neoplasm Metastasis, +15 more
- Locations
-
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
Completed
A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer
NCT02015416
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +37 more
- Locations
-
- Scottsdale Healthcare Scottsdale, Arizona, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00743496
- Conditions
- Ewing Sarcoma, Melanoma, Neoplasms, +21 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States